Home / Bicalutamide / Czechia
CZ ATC L02BB03 · updated 2 Nov 2026
Bicalutamide shortage in Czechia
Is there a Bicalutamide shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Bicalutamide products are reported short in Czechia, the first since 14 Aug 2026. The company estimate for the return is 31 Dec 2026 (latest 25 Jan 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Austria, Belgium, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | BICALUPLEX 150MG 150MG TBL FLM 28 | Teva Pharmaceuticals CR, s.r.o., Praha | 14 Aug 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | BIKALARD 150MG 150MG TBL FLM 90 I anticipated | ARDEZ Pharma, spol. s r.o., Kosoř | 1 Dec 2026 | 25 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.